CLOs on the Move

CRF Health

www.crfhealth.com

 
With operation centers in the United States and the United Kingdom and an R&D center of excellence in Finland, CRF Health is committed to driving the global change to higher-quality outcomes and more efficient paper-free clinical trials through improved patient engagement via intuitive and patient-focused eCOA (electronic Clinical Outcome Assessment) technology. By improving the process of conducting clinical studies, we help companies bring new medicines to market quickly, safely and more cost-effectively.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.crfhealth.com
  • 4000 Chemical Rd Ste 400
    Plymouth Meeting, PA USA 19462
  • Phone: 267.498.2300

Executives

Name Title Contact Details

Similar Companies

USAID

USAID is a Washington, DC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Nexeon MedSystems

Nexeon MedSystems, Inc is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Westwood Health Care Ctr

Westwood Health Care Ctr is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Allergen Research

Aimmune is a clinical-stage biopharmaceutical company advancing a new therapeutic approach, including the development of proprietary product candidates, for the treatment of peanut and other food allergies. Our mission is to improve the lives of people with food allergies by developing and commercializing proprietary desensitization therapies that safely and reliably protect them from accidental exposure to food allergens. We aim to address food allergies by providing a treatment option that goes beyond the current protocols of avoiding exposure to food allergens and carrying epinephrine for administration in case of accidental exposure. Our CODIT™ system is based on extensive independent scientific research demonstrating that most patients with food allergies can become desensitized to the allergens, or proteins, in a particular food through the oral administration of gradually increasing amounts of the allergens. In oral immunotherapy (OIT), a very small amount of an allergen is administered on a daily basis and then regularly increased until desensitization to a certain amount of the allergen has been achieved. We plan to develop and commercialize standardized, pharmaceutical-grade food allergens for our CODIT™ (characterized oral desensitization immunotherapy) system, our system for OIT. Our lead product candidate, AR101, is a standardized, complex mixture of 13 naturally occurring proteins and pharmaceutical-grade ingredients that, with the CODIT system of gradual, controlled updosing and ongoing maintenance dosing, has obtained meaningful desensitization to peanut allergens in our initial clinical studies.

Qbc Diagnostics Inc

Qbc Diagnostics Inc is a State College, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.